Gliclazide and Cholecystitis - a phase IV clinical study of FDA data

Summary:

Cholecystitis is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Metformin, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Cholecystitis when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Cholecystitis?

Cholecystitis (infection of gallbladder) is found to be associated with 1,185 drugs and 1,217 conditions by eHealthMe. Check the latest studies of Cholecystitis.

On Jul, 13, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 20 people (0.07%) have Cholecystitis.

Among these 20 people:

How long have people been on Gliclazide when they have Cholecystitis? *

What is the gender of people who have Cholecystitis when taking Gliclazide? *

female: 50 %
male: 50 %

What is the age of people who have Cholecystitis when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

Metformin: 9 people, 45.00%
Actos: 3 people, 15.00%
Rybelsus: 3 people, 15.00%
Metformin Hydrochloride: 3 people, 15.00%
Humalog Pen: 2 people, 10.00%
Trelegy Ellipta: 2 people, 10.00%
Incruse Ellipta: 2 people, 10.00%
Lisinopril: 2 people, 10.00%
Euthyrox: 1 person, 5.00%
Entresto: 1 person, 5.00%

What are other side effects people have besides Cholecystitis? *

Nausea And Vomiting: 6 people, 30.00%
Gallstones (stone formation by bile component): 5 people, 25.00%
Acute Kidney Failure: 4 people, 20.00%
Constipation: 4 people, 20.00%
Nausea (feeling of having an urge to vomit): 4 people, 20.00%
Fever: 3 people, 15.00%
Head Injury: 2 people, 10.00%
C-Reactive Protein Increased: 2 people, 10.00%
Flatulence (flatus expelled through the anus): 2 people, 10.00%
Weakness: 2 people, 10.00%

What are the existing conditions these people have? *

Weight Loss: 2 people, 10.00%
High Blood Cholesterol: 2 people, 10.00%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 1 person, 5.00%
Pituitary Tumor Benign: 1 person, 5.00%
Ill-Defined Disorder: 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Hepatocellular Carcinoma (liver cancer): 1 person, 5.00%
Hepatitis Viral: 1 person, 5.00%
Heart Disease: 1 person, 5.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Cholecystitis?

- Check whether Cholecystitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Cholecystitis treatments and more:

Cholecystitis (16,481 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholecystitis:

Cholecystitis (1,185 drugs)

Browse all the conditions that are associated with Cholecystitis:

Cholecystitis (1,217 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.